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Abstract: The first wireless camera pills created a revolutionary new perspective for engineers
and physicians, demonstrating for the first time the feasibility of achieving medical objectives
deep within the human body from a swallowable, wireless platform. The approximately 10 years
since the first camera pill has been a period of great innovation in swallowable medical devices.
Many modules and integrated systems have been devised to enable and enhance the diagnostic
and even robotic capabilities of capsules working within the gastrointestinal (GI) tract. This
article begins by reviewing the motivation and challenges of creating devices to work in the
narrow, winding, and often inhospitable GI environment. Then the basic modules of modern
swallowable wireless capsular devices are described, and the state of the art in each is discussed.
This article is concluded with a perspective on the future potential of swallowable medical devices
to enable advanced diagnostics beyond the capability of human visual perception, and even to
directly deliver surgical tools and therapy non-invasively to interventional sites deep within the
GI tract.
Keywords: swallowable devices, capsules, gastrointestinal tract, wireless capsule endoscopy,
robotic capsules, minimally invasive surgery, endoluminal devices, surgical endoscopy
1 INTRODUCTION
The often repeated assertion that wireless capsule
endoscopy (WCE) has rapidly become the preferred
method of small intestine diagnosis was underscored
recently by the May 2009 announcement of Given
Imaging, Inc. (the first commercial producer of camera
pills) that over 1 million of their PillCam capsules have
been used clinically. PillCams and other commercial
capsules (see Fig. 1) have been used to diagnose many
diseases including obscure gastrointestinal bleeding
(OGIB), cancer, celiac disease, and Crohn’s disease, all
of which occur in the small intestine [1]. Recently,
commercial WCEs have also been extending their
reach into other parts of the gastrointestinal (GI) tract
including the oesophagus and colon [1]. It is widely
agreed that enhancing this technology through the
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development of active, robotic capsules that can see,
diagnose, and treat will make health care more precise,
portable, and personal [2].
Because it requires only the simple and non-invasive
swallowing of a pill and no anaesthesia, modern WCE
offers an appealing alternative to traditional flexible
scope-based endoscopy for visualizing the interior of
the GI tract. In this article, only these wireless, swal-
lowable, and pill-like devices are considered. A review
of a number of tethered devices is available to the
interested reader in reference [3]. Similarly, related
technologies that are beyond the scope of this arti-
cle are those used in natural orifice and transluminal
endoscopic surgery (NOTES) devices, as discussed in
references [4] to [8]. Such devices typically require
anaesthesia, which implies low (but non-negligible)
risks of cardiopulmonary and other complications [9].
It has also been hypothesized that WCE may, by reduc-
ing the indignity and discomfort of endoscopic pro-
cedures, have the additional benefit of encouraging
many who currently forgo medically recommended
examinations (particularly colonoscopy) to have them
done [10].
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Fig. 1 Current commercially available swallowable camera capsules include (a) PillCam SB2, (b)
PillCam ESO, (c) PillCam Colon, all by Given Imaging, Inc., as well as (d) EndoCapsule
of Olympus, Inc., (e) OMOM of Jinshan Science and Technology Group, and (f) MiRo
of Intromedic Co. These capsules carry cameras into the GI tract for visual inspection.
While most of the capsules shown are designed for the small intestine, PillCam ESO is an
oesophageal capsule and the PillCam Colon carries two onboard cameras for use in the large
intestine. All capsules are 11 mm in diameter × 26 mm in length except for OMOM (13 mm
× 27.9 mm), MiRo (10.8 mm × 24 mm) [14], and PillCam Colon (11 mm × 31 mm) [15]
Robotic systems including sensors and actua-
tors have shown great promise in extending the
interventional and diagnostic capabilities of WCEs,
and the purpose of this article is to review the state
of the art in such systems. Because a number of
recent and thorough reviews of commercial passive
(imaging-only) camera pills are already available to
the interested reader (see references [1], [3], [11],
and [12]), the present authors treat them only briefly
here, providing a complementary review of recent
robotic advancements in swallowable sensors and
actuators, and the associated electronics, telemetry,
and power systems that enable them to work. A brief
survey of some (but not all) of these topics has been
given in reference [13], and in the current paper an
expanded review of all aspects of state-of-the-art WCE
technology is provided.
The sections that follow first discuss the unique
requirements of the various areas of the GI tract and
briefly treat commercial capsules. Then, a high-level
overview of the modules that can be included in a
robotic WCE is given, after which each module is dis-
cussed in depth. The article concludes in section 10
with a perspective on the role robotic technologies can
be expected to play in the future of WCE.
2 CAPSULE ENVIRONMENT ANDMODULES
The GI tract consists of oesophagus, stomach, small
intestine, and large intestine (or colon), each of which
presents different challenges for WCEs (see Fig. 2). The
oesophagus, which connects the throat to the stom-
ach, is a hollow, muscular tube that for an average
adult is approximately 25 cm long, and 1.5–2 cm in
diameter [16]. Oesophageal capsules (e.g. the PillCam
Fig. 2 A Schematic of the GI tract showing the oesopha-
gus, stomach, small intestine, and large intestine
(or colon), each of which present a unique set of
challenges for WCEs. The typical path of a WCE is
shown by the dashed black line. Note that the ori-
entation of a capsule along this path is arbitrary
due to the lack of active locomotion
ESO and ESO2 by Given Imaging, Inc.) require high
frame rates due to the rapid rate of progression (com-
plete transit in approximately 10 s [16]) of the cap-
sule within the oesophagus. Fortunately, since such
capsules only need to function for a few minutes,
battery life is a much lesser concern than in other
areas of the GI tract [12]. Oesophageal capsules can
also be used for longer-term monitoring when com-
bined with a braking or anchoring mechanism such
as legs [17,18] or magnets [19] (which are discussed
further in section 7). This is particularly useful in diag-
nosis of gastro oesophageal reflux disease (GERD),
which requires at least 24 hours of pH monitoring.
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The Medtronic Bravo Capsule, which does not col-
lect images, is designed for this purpose but requires
fixation to the oesophageal wall via an endoscopic
procedure [20].
After passing through the oesophagus, the capsule
reaches the stomach, a large, typically deflated elas-
tic sac that is lined with a thick mucous membrane
and contains gastric juices. In its deflated state, the
stomach contains many longitudinal folds, and at
the pylorus, the narrowest part of the stomach, it is
about 2 cm in diameter [16]. Owing to the challenge
of maintaining traction on the stomach wall, few cap-
sules have been purposely designed for this portion of
the GI tract, although prototypes have been developed
for a propeller-driven ‘swimming’ capsule [21] (see
section 7) and a multi-module assemblable and recon-
figurable robotic system consisting of several units
intended to be independently swallowed [22].
A capsule exits the stomach into the small intestine,
where WCEs have made their most significant clin-
ical impact. The small intestine is an elastic lumen,
3–4 cm in diameter, and is the longest portion of the
GI tract (approximately 670–760 cm in length). This
tubular structure, which winds and curves many times
in the abdomen, has villi coating its internal surface.
It normally contains semi-digested foods, pancreatic
juices, enzymes, and bile [16], although the food prod-
ucts are typically removed via ingestible agents prior
to capsule endoscopy. WCEs are pushed through the
small intestine via peristalsis (the natural muscle activ-
ity that normally moves decomposing food products).
Peristalsis generally occurs over short segments and
propagates at a rate of 1–2 cm/min [16]. Commercial
capsules designed for the small intestine (see Fig. 1)
include the PillCam SB and SB2 and Agile Patency Sys-
tem (a self-disintegrating pill [12]) by Given Imaging,
Inc., the EndoCapsule by Olympus, Inc., the OMOM
capsule by the Jinshan Science and Technology Group
Co., Ltd., and the MiRo capsule by Intromedic Co.
The Agile capsule, an accessory to the PillCam, can
be used prior to the ingestion of the PillCam SB to
verify adequate capsule passage through the GI tract
in patients with known or suspected strictures. This
capsule assists in detecting the problem of capsule
retention, which occurs in 0.75 per cent of OGIB
cases, but may occur at a rate of up to 6.7 per cent
in patients with Crohn’s disease [12]. While each of
these commercial capsules is designed for use in the
small intestine, they vary in the optical sensors (com-
plementary metal oxide silicone (CMOS) or charged
couple device (CCD)) used, their size, and their attain-
able frame rates. See section 5 for further information
as well as reference [14] for an in-depth review of
commercial camera capsule capabilities.
The last region of the GI tract encountered by a WCE
is the large intestine or colon, which measures about
150 cm in length and 6 cm in diameter [16,23]. While it
does not contain as many folds as the small intestine,
Fig. 3 Schematic diagram of possible modules in a
robotic wireless capsule
the large intestine contains two flexures (corners) that
a capsule must navigate around. The larger lumen
makes diagnosis difficult for capsules designed for
the small intestine because they tumble in the larger
lumen and generally cannot view the entire internal
surface. A number of devices have been designed to
work in the colon by entering through the rectum and
travelling against peristalsis (which is the approach of
standard colonoscopy) as reviewed in reference [3].
WCEs designed for the colon include PillCam Colon
by Given Imaging, Inc. and the legged capsule of
Valdastri et al. [10]. The time of passage of a capsule
through the entire GI tract is generally about 8–10 h,
with approximately 1 h spent in the stomach, 4 h in
the small intestine, and 5 h in the colon [24].
2.1 Robotic endoscopic capsulemodules
There are a number of modules possible in a robotic
WCE (see Fig. 3), although most capsules built to
date include only a subset of these due to space con-
straints.Whether it will ultimately be possible to create
a single robotic device with all of these modules that
can both diagnose and treat disease, or whether a
group of task-specific capsules will work coopera-
tively (a more likely initial scenario), a large number of
robotic modules will be required. The major modules
of a robotic capsule system are localization, telemetry,
vision, non-visual sensors, locomotion, interventional
systems, and power. Each of these modules individu-
ally poses a variety of worthy engineering challenges,
and integrating two or more of them is also challeng-
ing. Subsequent sections of this article discuss the
technical progress that has been made in each of the
general modules.
3 LOCALIZATION
To determine the location of lesions and other
structures visualized in capsule images (for future
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follow-up interventions or to enhance diagnosis) sys-
tems must be developed to measure the position and
orientation of the capsule when images are collected.
Useful spatial information includes the capsule’s posi-
tion in three-dimensional (3D) space, the distance it
has travelled along the GI tract, and the region of the
GI in which it is located. A number of methods for
obtaining localization information have been explored
in feasibility studies, including systems based on
radio frequency (RF) triangulation, magnetic tracking,
computer vision, and ultrasound, as described below.
3D position information can be obtained by both
RF triangulation and magnetic tracking. RF triangula-
tion systems typically use an external sensor array that
measures signal strength of capsule transmissions at
multiple points and uses this information to estimate
distance. This type of localization method is used in
PillCam SB systems [25]. However, the noisy nature
of distance estimates based on RF signal strength
resulted in an average experimental error of 37.7 mm
[26] in one study. A second approach to obtain 3D posi-
tion information is magnetic tracking of a permanent
magnet that is placed inside the capsule and detected
by a skin-mounted magnetoresistive sensor array [26].
Using both field strength and field direction, a cali-
brated sensor array can achieve an average position
error of 3.3 mm and an average orientation error of 3◦
[27]. This system uses a static magnetic field and can
collect measurements at 3.33–5 Hz. Another 3D mag-
netic detection system called 3D-MAGMA (Innovent
Technology, Germany), collects individual measure-
ments at 50 Hz, before filtering and processing to
provide accurate position information at a rate of 2 Hz.
It uses 27 sensors, achieving an accuracy of 5 mm and
2◦ [28], and also uses magnetic information to estimate
velocity.
Distance along the GI tract and determination of the
GI structure in which the capsule is located have been
approached through computer vision. While ‘dead
reckoning’ of distance along the intestine may seem
like an obvious approach for deducing capsule dis-
tance travelled, it is not straightforward. Commercial
(non–oesophageal) capsules capture images at only 2–
4 Hz (see section 5), and their motion is erratic (i.e.
they may spend relatively long periods of time station-
ary before moving forward rapidly a short distance,
and they may even flip over, aiming their camera back
up the lumen from where they came). Furthermore,
there are few distinctive features on the wall of the GI
tract for a computer vision algorithm to track. How-
ever, these difficulties have not prevented noteworthy
attempts at computer vision approaches to capsule
localization. One recent approach uses moving pic-
ture experts group (MPEG)-7 image features, vector
quantization, principal component analysis, and neu-
ral networks to classify images as belonging to the
upper or lower (i.e. the colon) GI tract and achieves
95 per cent accuracy [29]. Another computer vision
method uses an energy-based event boundary detec-
tion algorithm to identify different digestive organs
based on their unique patterns of muscular con-
traction, correctly classifying events with 76 per cent
accuracy [30].
Inertial sensing based on accelerometer data has
also been used for capsule localization [31]. In this
work, a 3 mm × 3 mm digital triaxial accelerome-
ter, which operates at 20 Hz, was integrated within
the capsule and data were transmitted over ZigBee
technology (see section 4) to an external computer.
This system successfully estimated orientation with 6◦
accuracy. It should also be noted that since acceler-
ation is directly measured, velocity can be obtained
more accurately than position because it requires
only a single integration. Another possible localiza-
tion approach is the use of ultrasonic pulses emitted
from outside the body and echoed by the capsule [32],
although this has not yet been directly tested in the
GI tract. The InteliSite and Enterion drug delivery cap-
sules (see section 8 for more information) use Gamma
Scintigraphy as a means of localization. This method
requires a radioactive agent be placed inside the cap-
sule so that it can be tracked using gamma cameras
[33]. A recent review of patent literature by Moglia
et al. [34] also discusses the possibility of combining
magnetics and X-ray imaging to localize a capsule [35].
3.1 Localization summary and challenges
Since the GI tract is a long tubular structure that folds
upon itself many times and is free to move within the
abdominal cavity, it is a challenging environment in
which to localize capsule position. Furthermore, the
GI tract lacks straightforward landmarks, making dis-
cernment of capsule location from image information
difficult even for trained physicians. However, identi-
fying the physical location of capture of each capsule
image is important in both diagnostic and therapeu-
tic applications of WCEs. This has lead to a number
of innovative approaches to the localization problem,
as reviewed above. However, these systems are cur-
rently at the proof of concept stage, and it remains
unclear which will be the most useful and easily
implementable, while providing sufficiently accurate
information, in future clinical WCE applications.
4 TELEMETRY
Endoscopic capsules rely heavily on wireless commu-
nication to transmit images and receive commands.
The two most important metrics defining the qual-
ity of capsule wireless telemetry are power efficiency
and data rate. Some capsules employ commercially
available telemetry chips, while others utilize cus-
tom purpose-built solutions, see reference [36] for
an overview. Given Imaging, Inc., for example, uses a
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custom telemetry chip produced specifically for their
PillCams, made by Zarlink, Inc. The power consump-
tion of this chip is 5.2 mW, and it has a data rate of
2.7 Mbps with a carrier frequency of 403–434 MHz [36].
This telemetry link is unidirectional and is used for
transmitting images out of the capsule only. Other cus-
tom unidirectional modules for image transmission
also exist. The system by Shen et al. [37] transmits on a
416 MHz carrier frequency at slightly lower power lev-
els (4 mW) and data rates (2 Mbps) than the Zarlink
chips described above. Thone et al. [36] developed
a similar design that transmits at 2 Mbps at only
2 mW of power consumption, using a 144 MHz carrier
frequency.
Bidirectional data transmission is often essential for
robotic capsules, which must receive and act upon
commands sent to them. ZigBee, which uses the IEEE
802.15.4 standard, has been applied for this purpose
in proof of concept experiments by Valdastri et al.
[39]. Developed with home and building automation,
industrial control and monitoring, wireless sensor
networks, and consumer electronics in mind, Zig-
Bee is characterized by low power, low data rate,
long battery lifetime, and high networking capability.
The data rate of ZigBee is 250 kbps, which is suffi-
cient for bidirectional transmission of control signals,
but not for images. An architecture applying ZigBee
together with a commercial microcontroller (CC2430
from Texas Instruments) for capsular endoscopy has
been developed by Susilo et al. [38] (see Fig. 4).
An innovative new method of information trans-
mission known as electric-field propagation exploits
the human body as a conductive medium for data
transmission. This has been applied in the new com-
mercial MiRo capsule by Intromedic Co. While power
levels and data rates have not yet been reported, it
is hypothesized that this method may offer higher
data rates with lower power consumption than existing
Fig. 4 Custom miniature telemetry and control circuit
boards developed by Susilo et al. [38], which uti-
lize ZigBee and a commercial microcontroller for
communication and control of a WCE
RF technologies due to the elimination of power-
consuming RF transmission components [40].
4.1 Telemetry summary and challenges
Data rates are limited in current unidirectional
telemetry links for video signals, which limit cur-
rent image transmission frequency to 2–4 Hz (see
section 5). Paths forward towards more rapid imag-
ing include improved image compression algorithms
(see section 5) and/or enhanced telemetry link tech-
nology, with electric-field propagation being the most
promising current technology. In designing a teleme-
try link, one must be concerned with not only keeping
electrical power consumption low and data rates high,
but also maintaining transmission signal power within
medically safe limits (see reference [39]) without sac-
rificing transmission link reliability. Robotic devices
often require bidirectional communication, and Zig-
Bee is the most promising current technology that has
been used in this application.
5 VISION
Capsular endoscopy owes its very existence to the
miniaturization and quality enhancements of cameras
that have taken place in the past several years [41],
which enabled the first camera pills. The goal of all
current capsule vision systems is to use onboard com-
ponents to obtain clear images of areas of interest in
the GI tract and to transmit those images efficiently to
an offboard platform for manual analysis by a physi-
cian or automated analysis by a computer algorithm.
Vision system enhancements are an active area of
WCE research, and efforts are underway towards
miniaturization, efficiency enhancements, improving
image quality and information content, and methods
of differentiating the few diagnostically useful images
from the many total images returned from the cap-
sule. Current commercial and research capsules and
capsule robots typically make use of miniature CMOS
[40,42,43] and CCD [44] imaging chips, and a detailed
review of their vision capabilities can be found in refer-
ence [1]. Briefly, there exists single (PillCam SB, Given
Imaging, Inc.) and multi-lens (PillCam SB2) solutions,
with four (PillCam SB) to six (Olympus EndoCapsule)
light emitting diodes (LEDs), viewing angles from 140◦
(PillCam SB) to 156◦ (PillCam SB2), and data rates of
2 Hz (PillCam, OMOM and Olympus capsules) to 3 Hz
(MiRo, Intromedic Co.). The PillCam SB, OMOM, and
MiRo store all images for later viewing, while the Pill-
Cam SB2 and the Olympus EndoCapsule provide the
capability of viewing images as they are acquired. The
oesophageal capsules (PillCam ESO and ESO2) require
higher data rates for shorter durations and include two
cameras capturing at up to 18 images per second with
a battery life of 20–30 min [42]. The lone example of
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a commercial capsule designed for the colon (PillCam
Colon) also has two cameras capturing images at 4 Hz
each. Because it can be switched off until the capsule
reaches the colon, the device has a battery life quoted
at 10 h [1], but its active period is shorter.
5.1 Image acquisition hardware
To obtain clear images, modern endoscopic capsules
rely on onboard image acquisition hardware including
a vision sensor, lens, illumination source, and image
compression chip. These combine to deliver images
(see Fig. 5 for an example), the quality of which can
be described by metrics for colour resolution, spatial
resolution, and frame rate [45]. As mentioned above,
most image acquisition chips are currently based on
CMOS technology, with the exception of the Olym-
pus EndoCapsule, which uses CCD. When compared
with the PillCam SB, it has been shown that the
EndoCapsule generally scores higher in image quality
and resolution, but both yield comparable diagnos-
tic performance [46,47]. CMOS technology has also
been applied to a variety of robotic capsules within
the Versatile Endoscopic Capsule for Gastrointestinal
Tumor Recognition and Therapy (VECTOR) European
project, where a monolithic 320 × 240 active-pixel
colour-RGB or grey level camera-on-a-chip sensor was
developed and tested in the ex-vivo setting [48,49].
There has also been some recent work aimed at com-
bining ideas from CMOS and CCD chips to create
improved hybrid cameras [41].
Optics are also important for high-quality vision,
and there has been some work towards developing
autofocus lenses. A prototype system by Cavallotti
et al. [14] uses a liquid lens actuated by a pulse
width modulated signal to adjust focal length from
30 to 100 mm. Good illumination is also essential for
Fig. 5 View of a bleeding lesion in the small intestine,
captured by a PillCam SB (image courtesy of
Rajesh Kumar, Johns Hopkins University)
high-quality imaging and can even yield enhanced
information beyond human visual capacity. Promising
techniques include chromoendoscopy and autofluo-
rescence (light working in conjunction with dyes and
chemicals applied to the intestinal lining), confocal
laser endomicroscopy (for real-time histology), and
spectroscopy (which has been used to detect dys-
plasia) [50]. Endoscopic capsules may in the future
serve as a platform for carrying many of these and
future optical diagnosis techniques deep into the
GI tract.
5.2 Image compression and software
Image compression is required for rapid image trans-
mission over the relatively low data rate telemetry
links described in section 4. The images collected
from capsule-based cameras generally contain a large
amount of information (a VGA image with 8-bit colour
information contains 2.45×106 bits, and many current
capsules capture at 1/4 this resolution) before com-
pression. Since capsules have limited power, compres-
sion must be efficient both in terms of electrical power
and time, while retaining the essential information
stored in the image. The exact level of compression
necessary depends on the application and the medical
objective of the capsule. While current PillCams pro-
duce diagnostically useful results, there is little debate
that higher frame rates would be desirable. For future
robotic capsules that may be teleoperated by a physi-
cian, it is likely that frame rates of 20 or more will be
required [51].
Some capsule image compression algorithms pro-
cess the images acquired in two steps: demosaicking
and transforming from RGB space to YCbCr space,
before quantizing the image for compression [52]. One
example that uses this standard compression tech-
nique, but implements a prediction algorithm as its
underlying principle, can obtain compression ratios
of 20. Using this technique, a 4 mm2 compression chip
that consumes only 7.5 mW has been fabricated [51].
Another low-powered image compressor developed by
Lin et al. skips the preprocessing steps of demosaick-
ing and colour-space transformation by starting with
the raw images in Bayer pattern format and then pro-
cessing the R, G1, G2, and B signals separately. This
technique reduces the computation load required to
compress images by 75 per cent at 14.92 mW of power
[52]. When compressing images, it is also important
to conserve memory allocation that requires space
onboard the capsule [51]. One approach that specif-
ically addresses this uses a Bayer colour filter array to
achieve performance comparable to a more complex
wavelet-based coder, while maintaining low power
consumption [53].
Advancements have also been made in software
for onboard or offboard analysis of capsule images.
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Onboard software can enable closed-loop control of
camera orientation for improving image quality [54].
It can also be used for in-situ capsule video analysis
in order to detect and predict upcoming video images
that may be of concern to a clinician [55]. External
postprocessing software for capsule images is also
extremely useful because a typical small intestine cap-
sule will return approximately 50 000 total images from
a single use [56], but only a very small fraction of these
images will contain useful diagnostic information. For
this reason, algorithms are under development to sort
these images and guide the physician to the most
important frames, with the future intent of aiding
the physician by automatically suggesting appropriate
diagnoses for lesions identified [56].
5.3 Vision summary and challenges
The challenges in vision involve obtaining clear, sharp
images of diagnostically useful areas of the GI tract and
compressing them sufficiently (with minimal infor-
mation loss) for fast transmission over the telemetry
link. While the current performance of capsule-based
cameras (typically 2–4 Hz at 1/4 VGA resolution) is
good enough for some diagnostic tasks and per-
haps for some future automated robotic tasks that do
not involve real-time human interaction, there is lit-
tle debate that speed and resolution improvements
would be desirable. Such improvements will be nec-
essary to enable some future teleoperated robotic
capsules envisioned by researchers, which will require
imaging at approximately 24 fps so that the images
returned have the appearance of video to the human
operator. Unless there are dramatic breakthroughs in
telemetry, advancements towards this goal are likely to
include increasingly sophisticated image compression
algorithms. It is also important to develop automatic
image analysis algorithms in both the onboard and
offboard contexts, to assist with real-time control and
identification of the few diagnostically useful images
among the thousands typically returned, respectively.
6 DIAGNOSTIC SYSTEMS BEYOND IMAGE
ACQUISITION
It is in principle possible to carry a wide range
of biosensors onboard a capsule. Quantities that
have been measured to date by capsule-based sen-
sors include pH, pressure, oxygenation, electrical
conductivity, temperature, and blood detection. An
example of a capsule with integrated pressure, tem-
perature, and pH sensing capabilities is presented in
reference [45].
pH sensing can detect acidic reflux, and impedance
monitoring can detect non-acidic reflux, both of which
are useful diagnostically. Gonzalez-Guillaumin et al.
[19] developed a swallowable capsule that can perform
Fig. 6 Prototype of the pH-sensing capsule that uses a
voltage difference to measure pH and half-ring
electrodes for impedance sensing (©2007 IEEE)
[19]
both of these tasks, as shown in Fig. 6, providing 24-h
monitoring for the detection and evaluation of GERD.
One noteworthy aspect of this design is its ability to be
held to the oesophageal wall through an external mag-
net placed near the throat. This may be an advantage
over the Medtronic Bravo Capsule, which is designed
for the same clinical objective but requires thin metal
spikes for attachment to the oesophageal wall [20].
Temperatures can be measured in the GI tract by the
VitalSense ingestible telemetric physiological moni-
toring system, that uses thermistor-based sensing, as
well as the CorTemp pill system that uses the frequency
of oscillation of a crystal for temperature sensing [57].
Other pH and temperature measurement capsules
include the Philips iPill (also discussed in section 8)
[8,58] and a design by van der Schaar et al. that can
also expel a small amount of liquid [34]. Two other
sensing capsules reviewed in reference [13] include
the Lab-on-a-Pill capsule [59] which can sense pH,
conductivity, and oxygen levels, and a patented design
known as the Stanford endocapsule [60] that alludes
to optical, chemical, temperature, and pH sensing
capabilities. Moglia et al. [34] also review other recent
patents on capsule-based biosensors.
There has also been research towards detecting
blood in the intestine and stomach via microsensors.
Researchers from the VECTOR project, in collabora-
tion with novineon Healthcare Technology Partners
GmbH and Sensocor Ltd. developed a system con-
sisting of a bleeding detection capsule (ingestible
and implantable versions) that communicates with
an external event monitor. LED’s onboard the capsule
emit red and blue light, identifying the presence of
blood by transmission spectroscopy.
Another diagnostic capability that would be useful
onboard a capsule is optical biopsy. Standard biopsy
in the colon currently requires ten relatively large (2–
3 mm3) tissue samples to be taken from the same loca-
tion and analysed within 1–2 h of extraction, which are
JMES1879 Proc. IMechE Vol. 224 Part C: J. Mechanical Engineering Science
1404 J LToennies, GTortora,M Simi, PValdastri, and R JWebster III
challenging (and perhaps impossible) requirements
for a mobile swallowable capsule. Optical biopsy pro-
vides a potential alternative using the properties of
light for diagnosis. Promising imaging techniques for
optical biopsy include fluorescence endoscopy, opti-
cal coherence tomography, confocal microendoscopy,
light-scattering spectroscopy, raman spectroscopy,
and molecular imaging, all of which are discussed in
detail in reference [61].
6.1 Sensing summary and challenges
Significant challenges in integrating sensing onboard
WCEs are in developing and miniaturizing the biosen-
sors themselves. Additional challenges arise in pack-
aging them onboard the capsule where they must be
shielded from unwanted environmental contact and
exposed when desired. As with all other capsule com-
ponents, sensors must also be power efficient and
able to be integrated with other modules. A number
of promising sensing methods have been developed
including sensors for pressure, temperature, electri-
cal conductivity, and pH, and optical biopsy tech-
niques hold great promise for extending the diagnostic
capabilities of endoscopic capsules.
7 LOCOMOTION
Current commercial capsules move through the GI
tract by means of peristalsis alone. However, such
movement is unpredictable and inconsistent, which
results in incomplete evaluations approximately 20
per cent of the time [62]. Performance is even worse
in the large intestine, where the sensitivity of capsule
endoscopes for detecting colonic lesions is low com-
pared with the use of conventional colonoscopy [15].
Active locomotion has the potential to improve cap-
sule imaging consistency and coverage, by enabling
the capsule to suspend itself in the middle of the lumen
and move forward, backward, and to stop in place at
areas of interest [10]. Two main approaches have been
developed for WCE locomotion: (a) internal and (b)
external. Internal locomotion is defined as the use
of micromechanisms integrated solely onboard the
capsule platform for locomotion. In contrast, exter-
nal locomotion utilizes propulsive forces transmitted
by an external system, typically a magnetic field.
7.1 Internal locomotion
Advantages of internal locomotion are the ability to
obtain precise motion relative to the lumen due to
local contact, and the fact that no external magnetic
field generators are required. Another advantage of
some mechanisms (such as legs) is the ability to simul-
taneously distend tissue away from the camera lens
[10]. The major drawback is the need to supply rel-
atively large actuators with a significant amount of
power. A number of different internal locomotion
strategies have been developed over the past few years,
as discussed below.
Vibratory actuation can aid the forward progression
of a capsule along the GI tract by reducing friction
with its environment [63]. Here, the capsule contains
a micromotor with an assymetric mass on the rotor to
create vibrations around its central axis.The advantage
of this method of locomotion is its mechanical sim-
plicity. Challenges include lack of active orientation
control and difficulty obtaining good images during
vibration. Furthermore, the capsule cannot actively
hold a given position or reverse direction and travel
back up the intestine.
Another means of locomotion inspired by biology
that has been applied to WCEs is earthworm-like
motion. Kim and colleagues [64] have developed
two prototypes, one 13 mm in diameter by 33 mm
in length, and another 15 mm in diameter by 30 mm
in length [65,66], as shown in Fig. 7 (left). The first
device propels itself by cyclic compression/extension
of shape memory alloy (SMA) spring actuators, while
alternately anchoring its ends to a surface using direc-
tional spines (micro needles) mounted at each end.
The locomotion method of the second prototype is
the same as the first, but it consists of two bel-
lows joined by a custom impact-based piezo actuator.
Both designs were tested in ex-vivo porcine intestine
and achieved velocities of 0.85 cm/min (one point
of contact) and 1.47 cm/min (three points of con-
tact) for the first prototype, and 13.38 cm/min with an
11 mm stroke for the second prototype. The first pro-
totype moved slower than the second due to the time
constants associated with heating and cooling SMA
actuators. Directional spines provide the advantage of
a passive anchoring mechanism that does not require
power or additional actuators, but likely at the expense
of precluding bidirectional motion.
Another bio-inspired solution is a cilia system for
locomotion [67]. The 15 mm diameter by 35 mm long
capsule contains six units (intended to mimic biologi-
cal cells), with two appendages that extend from each
unit (mimicking cilia extensions). Each unit is driven
by two SMA actuators to enable bidirectional motion
at a maximum velocity of 2.4 cm/min. However, the
power consumption of this design is currently high due
to numerous SMA actuators. In order to increase fric-
tion with the intestinal wall, design optimization of the
leg-like cilia extensions has also been performed [68].
It is also possible to produce locomotion in the GI
tract using a ‘paddling’ technique where leg-like fins
travel the length of the capsule [69]. At the back of the
capsule, the fins retract before recycling to the front of
the capsule for the next paddle stroke. An advantage
of the paddling motion is the rapid velocity it enables
of up to 18–36 cm/min depending on the number of
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curves in the section of the GI it traverses, although
it does not appear to be able to achieve bidirectional
motion in its current form.
Including legs on a capsule has been found use-
ful for both anchoring and locomotion in the GI
tract. A robotic capsule with an anchoring mecha-
nism designed for the oesophageal region of the GI
tract has been developed by Tognarelli et al. [18]. The
design uses three nitinol flexible legs with compliant
feet that deploy when released by a motor and can
be retracted again when desired. A design similar in
intent though employing a different anchoring foot
design is a capsule that uses legs with bio-inspired
feet that enhance adhesion to the oesophageal wall
[17]. This design is envisioned as a follow-up device
to initial diagnosis and localization of pathology by
current commercial capsules for somewhat longer-
term or higher image quality monitoring. Extending
the idea of this anchoring mechanism using micropat-
terned adhesives, Karagozler et al. [70] combine two of
the anchoring modules together to develop a locomo-
tion module for an endoscopic capsule. This capsule
has six legs, three on each end, that are actuated by
coil-type SMA wire in an alternating fashion to mimic a
crawling motion. As in models discussed above, intrin-
sic cycle time and power consumption limits of SMA
actuators limit actuation efficiency and speed.
Fully bidirectional legged locomotion has been
developed over the past 10 years at the Italian Cen-
ter for Research in Microengineering through a series
of increasingly sophisticated legged robot prototypes.
The first prototypes included six SMA-actuated legs
[71]. The short functional lives of the SMA actuators
and mechanical complexity of the design prompted a
move to the use of miniature brushless DC motors,
and designs incorporating 4 legs (12 mm in diam-
eter and 40 mm in length) [72], 8 legs (12 mm in
diameter and 40 mm in length) [73,74], and 12 legs
(11 mm in diameter and 25 mm in length) [10,75] have
been developed. This latest design (see Fig. 7(centre))
contains all mechanical components in a capsule
matching the size of commercial camera pills, is able
to distend tissue in a uniform manner with six points
of contact at each end of the capsule (enhancing cam-
era visibility and locomotion), and has the ability to
travel the length of the colon in a time compara-
ble to traditional colonoscopy [10]. All of the above
legged designs benefit from optimized, bio-inspired
leg geometry, which has included flexure-based knees
and careful consideration of foot geometry for safe and
high-friction contact with the intestinal wall [76,77].
Some advantages of legged locomotion include the
ability to control capsule position and orientation,
anchor and release the capsule as desired, and dis-
tend the colon away from the camera lens without
insufflation.
A promising new approach for locomotion in a
liquid-filled GI environment (particularly the stom-
ach; the patient can be instructed to drink liquid prior
to swallowing the capsule) is propeller propulsion [21],
as shown in Fig. 7(right). A propeller-driven capsule
acts as a miniature submarine, steering itself in a liq-
uid environment by actuating its propellers according
to direction, speed, and rotation commands input by a
human operator using a joystick. The velocity of initial
prototypes using this approach was 120–140 cm/min,
but they do require full immersion in a liquid environ-
ment in order to work. Other innovative methods of
locomotion (see reference [41]) include electrostimu-
lation of GI muscles [78–80] and flagellar swimming
[81]. In addition, some patents allude to the possi-
bility of locomotion through magnetically actuated
propellers [82], and self-propulsion through a fluid jet
[83], but these mechanisms have yet to be studied in
depth.
7.1.1 Internal locomotion summary and challenges
While, as described above, many innovative mech-
anisms for onboard capsule locomotion have been
devised, there remain a number of challenges in mov-
ing them from research laboratories to the clinical set-
ting. These include (a) making the mechanisms cheap
enough to be disposable (which may be preferred)
or robust and well-sealed enough for sterilization, (b)
making them efficient enough that they can run for a
Fig. 7 Photos of various capsules that utilize internal locomotion: (left) an earthworm-like capsule
that uses SMA actuation for extension and contraction (©2005 IEEE) [65], (centre) the
12-legged capsule developed by Valdastri et al. [10,75], (right) a propeller-driven capsule
that acts like a miniature submarine in the stomach [21]
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sufficient length of time on miniature batteries (for
example, see reference [10] for a discussion of the
power requirements of the dual brushless motorlegged
design and associated electronics and image capture
equipment), (c) making complex mechanisms small
enough to fit within a swallowable package (many
existing initial prototypes have been larger than this
for proof of concept), and (d) integrating locomo-
tion mechanisms with the other modules described in
Fig. 3, while maintaining overall dimensions at a swal-
lowable size. Some of these issues are addressed, albeit
at the cost of a significantly more complex overall sys-
tem, by the external locomotion techniques discussed
in the next section.
7.2 External locomotion
The primary approach to imparting forces and torques
to a capsule through a system external to the patient
has been through the use of magnetic fields. Mag-
netic actuation of internal devices has previously been
demonstrated in guiding catheters (e.g. the Niobe
system of Stereotaxis, Inc.) [84] and in wireless micro-
robots designed for use in the human eye [85,86] and
in capillaries [87].
The main advantage of using magnetic fields to con-
trol capsule position and orientation is the reduction
in onboard space requirements for actuators, actua-
tion mechanisms, and batteries. Primary challenges
include determining the direction and strength of
the magnetic field that should be applied to achieve
desired capsule forces and torques, and dynamically
modeling the capsule and intestine sufficiently well to
enable control of positions and velocities via applied
forces and torques. A trade-off in magnetic system
design is the choice of coils versus permanent mag-
nets for field generation. Coils can provide better
control of field strength and direction, whereas perma-
nent magnets can generate higher fields in a smaller
form factor. Another critical limitation of external
magnetic locomotion is that it is challenging to imple-
ment in a deflated lumen, although wireless insuffla-
tion systems have been proposed to overcome this
obstacle [88].
Owing to the potential advantages, there are a
number of current efforts underway to create a mag-
netically guided capsule. The Norika Project Team was
one of the earliest groups to utilize magnetic fields for
capsule motion, when they developed a capsule that
has three internal coils that interact with three external
coils embedded in a jacket worn by the patient for cap-
sule rotation [12,89]. In any such system, optimization
of the external magnetic field [86] is necessary to con-
trol the capsule, and approaches have been developed
using three orthogonal coil pairs [90], which can be
placed around the abdomen. Olympus has also been
developing a magnetically actuated capsule that has
an internal permanent magnet that interacts with a
Fig. 8 Olympus magnetic capsule concept. The cap-
sule is propelled by a rotating magnetic field that
causes a helical ridge on the outside of the capsule
to interact with the intestinal wall
varying, controllable, rotating field created by three
pairs of external electromagnets (see Fig. 8). Rotating
the external field, the capsule can be propelled forward
or backward using a spiral ridge wrapped around its
body [12].
Given Imaging, Inc., also has research underway
towards developing a magnetic actuation system as
part of a European FP6 project called Nanobased
Capsule-Endoscopy with Molecular Imaging and Opti-
cal Biopsy [91]. As an alternative to external field
generation using coils, Given Imaging is using an
external hand-held plate magnet to generate the mag-
netic field. In initial feasibility studies, Given Imaging
capsules have been modified to include magnetic
material and an external permanent magnet was used
to manipulate the capsule under gastroscopic visu-
alization [91]. The Korean Institute of Science and
Technology has proposed to control the magnetic field
using an external permanent magnet fixed on the end
effector of a Cartesian robot [92]. The system has a
total of six degrees of freedom (DOFs): three from the
robot, two from a rotary joint unit that rotates the
magnet, and one from the adjustable, rolling bed of
the patient. This idea has been studied in more depth
by Ciuti et al. [31], who developed a user interface for
control of a six-DOF industrial robot with a permanent
magnet fixed to its end effector, as shown in Fig. 9. This
system exploits the field strength obtained by a per-
manent magnet together with the precise control of
magnet position afforded by the robotic manipulator.
The Stereotaxis system mentioned above, which was
designed for catheters, has also recently been success-
fully applied to endoscopic capsule locomotion [93].
However, rather than design a new capsule with inter-
nal magnets, a magnetic shell was created for existing
commercial camera pills. A silicone sleeve mixed with
Neodymium–Boron–Iron can be used for this purpose
[94]. Although this system can be used for orienting
the capsule, because it cannot apply field gradients,
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Fig. 9 An external magnet attached to the end effector
of an industrial robot can be used to manoeuvre
a capsule containing internal magnets through
ex-vivo porcine intestine [31]
its translational capabilities are limited. Advantages of
this approach are its easy integration with commer-
cial magnetic control and endoscopic capsule systems
and its low cost (assuming that the Stereotaxis system
and capsule are already owned by the hospital imple-
menting it, otherwise it would be rather expensive).
Proof-of-concept experiments support the feasibility
of such a system and suggest further work in shell
optimization [93].
7.2.1 External magnetic locomotion summary and
challenges
As discussed above, the primary challenges in exter-
nal magnetic locomotion involve adequately control-
ling the magnetic field and producing locomotion in
deflated portions of the GI tract. Furthermore, one
intrinsic drawback to the approach is the complex-
ity and size of the equipment needed to generate the
Fig. 10 Image from a recent patent of a design for a
hybrid capsule that includes internal magnets
and a single set of three legs actuated by a DC
motor. This robot is designed to be primarily
actuated via magnetic fields, with the legs used
to assist when needed in tissue distention and
capsule locomotion [95]
magnetic field. Such equipment may involve signifi-
cant additional financial costs, which will likely require
specialized hospital facilities, and precludes the pos-
sibility of using capsules in small clinics and doctor’s
offices away from the hospital setting. However, the
compelling advantage of the external magnetic loco-
motion approach is that it reduces or removes the
need for batteries, actuators, and locomotion mech-
anisms onboard the capsule itself, where space is
at a premium. One path forward may be a hybrid
internal–external strategy with the aim of combining
the benefits of both approaches. An example of such a
system is described in a recent patent [95] (see Fig. 10),
which is primarily magnetically actuated, but uses legs
to assist with capsule motion, and orientation, and
tissue distention when needed.
8 INTERVENTION ANDTISSUEMANIPULATION
A significant limitation of modern commercial cap-
sules is that they are strictly diagnostic devices and
cannot treat the lesions they encounter directly. Thus,
with more severe lesions (or for more thorough diag-
nosis by, e.g. biopsy), it can be necessary to perform
subsequent surgery. This is why localization of cap-
sules during image capture is currently so important
(see section 3). While as reviewed in previous sec-
tions, many advancements have been made in cap-
sule visualization and diagnosis, the interventional
capabilities of capsules are comparatively in their
infancy. However, some interventional capabilities
have been demonstrated on proof-of-concept proto-
types, including topical drug delivery, clip deployment
to stop bleeding, and biopsy sampling.
A wireless endoscopic capsule for clip deployment
developed by Valdastri et al. [96] is the first therapeu-
tic capsule of its kind and has been demonstrated
in in-vivo animal trials [96]. This capsule, shown in
Fig. 11, has four internal permanent magnets enabling
external locomotion via magnetic fields. The cap-
sule contains a single pre-loaded SMA clip at one
end, which can be fired by the action of a miniature
motor housed inside the capsule, based on a wireless
command issued by the human operator.
Another therapeutic capsule that can deliver topical
drugs within the intestine is the iPill, under devel-
opment by Philips, Inc. [8,58]. This capsule, which
does not include a camera (also discussed briefly in
section 6) aims to take internal measurements such
as temperature and pH levels, wirelessly transmit the
data to an external receiver, and deliver a topical treat-
ment agent on command. It is hoped that the ability
to deliver drugs directly at the source of the problem
will lower the dosage levels and thus reduce unwanted
side effects. Applications envisioned include treating
colitis, Crohn’s disease, and cancer [8,58]. Other drug
delivery capsules (see also reference [13] and [33] for
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Fig. 11 Clip deployment capsule of Valdastri et al.
(©2008 Georg Thieme Verlag KG) [96]. (Left)
The capsule is oriented toward the lesion using
external magnetic locomotion. (Right) At the
command of the human operator a wireless
signal triggers clip deployment, clamping the
lesion and stopping bleeding
good discussions on this topic) include the InteliSite
(Innovative Devices) capsule that uses SMA wires to
line up perforated inner and outer sleeves to disperse
a drug through the holes [33], and the Enterion cap-
sule (Phaeton Research and Pharmaceutical Profiles)
that can deliver a treating agent (liquid, powder, semi-
solid) using a piston/spring actuation system [33].
A biopsy device consisting of a rotational razor for
cutting tissue attached to a torsion spring has also
been implemented onboard a capsule platform [97].
This device, tested ex-vivo in animal intestine, was
successful in extracting a tissue sample. However, it
is not yet clear whether such a mechanism will be
able to collect a sufficient number or volume of sam-
ples for accurate external histological analysis. Some
additional ideas for intervention and tissue interaction
have also recently been the subject of patent disclo-
sures [34], and one concept consists of a dual capsule
camera-biopsy system, where the two capsules are
connected by a tether [98]. Capsules housing ultra-
sonic transducer modules have also been sketched in
patents by Miyake [99] and Taniguchi [100].
8.1 Intervention and tissuemanipulation
summary and challenges
Interventional capabilities are one of the most promis-
ing areas of endoscopic capsule research. Developing
a system that can see, diagnose, and treat lesions it
finds is compelling from the perspectives of reduc-
ing invasiveness for the patient and reducing the
financial costs of treating GI diseases. Endowing
capsules with interventional capabilities is challeng-
ing due to the intelligence and miniature mecha-
nisms required in diagnosis and treatment. However,
providing clinical capsules with the interventional
capabilities mentioned above or others yet to be devel-
oped has the potential to make WCEs a much more
powerful weapon with which physicians can combat
disease.
9 POWER
Since nearly every other module relies on it, the
power source is a critical issue for robotic endoscopic
capsules. Commercial endoscopic capsules rely on
silver-oxide watch batteries, which are the only bat-
teries of their kind approved for clinical use [1]. These
batteries provide 3V at 55 mA-hr for approximately 8 h,
which implies an average power delivery of approxi-
mately 20 mW [101]. However, these traditional bat-
teries are neither energy dense enough nor able to
source the peak currents needed to power robotic
capsules–particularly those with internal locomotion
capabilities.
In general, large-scale battery technologies do not
scale down well to capsule dimensions [88]. One pos-
sible exception to this rule are Lithium Ion Polymer
batteries (LiPo), such as those available from Plantraco
and PowerStream, which are close to the size needed
for capsule integration. LiPo batteries have the highest
energy density (approximately 200Wh/kg) available in
off-the-shelf batteries, are capable of supplying peak
currents up to 20 times their nominal current [41], and
are miniaturizable, making them good candidates for
a robotic endoscopic capsule power source.
Valdastri et al. elaborate on the power requirements
of their legged capsule design, noting that the aver-
age power required for their 12-legged capsule was
measured to be 430 mW, plus an additional 180 mW
for the real-time vision system incorporated on their
prior prototypes. They come to the conclusion that
a 100 mA-h battery would be sufficient for powering
their robotic capsule that is actuated by two brushless
DC motors. The smallest (10 mm diameter and 30 mm
length), battery they were able to identify provid-
ing a capacity above 100 mA-h is the TLM-1030 from
Tadiran, Israel [10]. Thus, advancements in battery
technology are clearly needed, together with capsule
mechanism efficiency enhancements. Note, however,
that it is in principle possible to manufacture custom-
shaped LiPo batteries, so that it may be possible to
shape the battery to fill whatever space is available
within a capsule prototype. Thus, while it is not impos-
sible to include batteries onboard robotic WCEs, it is
clear that alternative methods of power would also be
valuable, and some are being developed.
Inductive coupling provides a means of wirelessly
transferring power to a capsule and is used in the intra-
corporal video probe [102]. This technique utilizes
three internal coils onboard the capsule, which derive
power from a magnetic field established by an exter-
nal solenoid coil (see Fig. 12). This system is capable
of providing 150 mW of power at any time while also
remaining below the specific absorption rate limit of
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Fig. 12 (Left) Prototype capsule developed by Lenaerts et al. (©2007 Elsevier) [102], which
is capable of transmitting 150 mW through inductive coupling. (Right) The prototype
fluid-powered capsule of Toennies and Webster [88]
the patient’s body. Carta et al. [103] extended this
concept to power a propeller-driven capsule (see also
section 7). Their design achieved 200 mW of power
transfer (compared to 100 mW required for their appli-
cation), and demonstrated that power transfer can be
enhanced by the use of a ferromagnetic core within
the capsule. The NORIKA Project Team has also pro-
posed the use of inductive coupling to power a capsule
that houses a CCD imaging chip, has focus adjustment
capabilities, and has a mechanism that allows for cap-
sule rotation (see section 7). The concept is that the
patient would wear a coil vest for power transmission
and direction control [89]. The coil vest worn by the
patient (also mentioned in section 7) is used for both
power transmission and direction control.
Another potential future power source, which
promises dramatic improvement in energy and power
density over conventional batteries, is the use of
chemofluidic phase transition to generate pneumatic
pressure. This ‘fluid power’ concept was initially
demonstrated in a prosthetic arm by Goldfarb et al.,
where experiments indicated that it could improve the
energetic figure of merit (a metric that encompasses
power source energy density, conversion efficiency,
and actuator power density) by an order of magnitude
[104]. It was thus concluded by Goldfarb et al. that
fluid power has the potential to be the lightest pos-
sible system capable of delivering a given amount of
power and energy. Based on this,Toennies andWebster
[88] proposed the idea of utilizing fluid power in cap-
sule robots, and performed initial experiments using it
for wireless insufflation, as a first step towards actuat-
ing more complex mechanisms within a capsule robot.
It is noted that a beneficial potential aspect of fluid
power is that ‘waste gas’ expelled after actuation can
help to insufflate the intestine, easing capsule passage
and increasing the area of intestine wall viewable in
each camera image.
9.1 Power summary and challenges
Powering endoscopic capsule robots is the single
greatest challenge facing researchers developing these
robots today. While current capsules using modern
battery technology can achieve some of the goals their
designers envision, many remain out of reach due
to power limitations. For capsule robots to achieve
their full potential, they will require enhanced batter-
ies or alternative sources of power such as inductive
coupling, fluid power, or other novel technologies to
be developed at the scales, power levels, and cur-
rent sourcing capacity necessary for powering capsule
robot systems.
10 CONCLUSIONS
While swallowable medical devices present substantial
engineering challenges, the promise of non-invasive
diagnosis and intervention deep within the body pro-
vides compelling motivation for their development.
The variety of possible GI environments, diagnostic
and interventional objectives, actuation and sens-
ing strategies, and human operator interfaces inspire
many diverse, innovative robotic WCE approaches.
Table 1 illustrates the diverse efforts in the develop-
ment of robot capsules to date.This diversity of designs
and medical objectives creates a number of possible
paths forward in WCE research. The most likely near-
term advancement (already underway) is the inclusion
on basic commercial WCE platforms of increasingly
sophisticated biosensors, vision systems, and liquid
topical drug delivery capabilities. Another near-term
advancement already underway is in software systems
to assist with identifying diagnostically useful images
and automatically analysing them to suggest likely
diagnoses.
In the slightly longer term, one can expect to
see clinical implementation of the most successful
locomotion and anchoring mechanisms derived from
prototypes currently under development in research
laboratories today. It is likely that progress will
continue in both internal and external locomotion
and anchoring mechanisms, and even possibly in
novel hybrid combinations of internal and external
locomotion. Fluid-powered wireless insufflation may
be an enabler of these future systems, enhancing
locomotion and visualization. Eventually, it is likely
that fully robotic capsules will be implemented.
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Table 1 A sampling of capsule robots and the different modules they contain. No one system to date contains all possible
modules described in this article. ‘—’ indicates that the capability either does not exist or has not yet been explicitly
reported, to the best of the authors’ knowledge; ‘a’ indicates that the capability appears to exist, but no details
have been provided; RF indicates radiofrequency; telemetry may be either (U)nidirectional or (B)idirectional;
sensing may be (I)nertial, (P) for pH, (T)emperature, (O)xygen, or (E)lectrical; locomotion may be (I)nternal or
(E)xternal; power may be (B)attery, (W)ireless, (M)agnetic, or (T)ethered. This table is intended to be exemplary,
not comprehensive
Literature Commercial Localization Telemetry Sensing Locomotion Power Vision Intervention
PillCam [1,42] ◦ RF U — — B CMOS —
EndoCapsule [1,44] ◦ RF U — — B CCD —
MiRo [1,40] ◦ RF U — — B CMOS —
OMOM [14,43] ◦ RF U — — B CMOS —
NORIKA [12] ◦ a U — E W CCD —
Bravo pH [20] ◦ Anchored U P, E E B — —
VitalSense [57] ◦ — U T — B — —
CorTemp [57] ◦ — U T — B — —
iPill [58] ◦ Time U P, T — B — Drug
InteliSite [33] ◦ Nuclear U — — W — Drug
Enterion [33] ◦ Nuclear a — — W — Drug
Magnetic [31] — Inertial B I E M CMOS —
pH [19] — Anchored U P, E E B — —
Lab on a Pill [59] — — U T, P, E, O — B — —
Vibration [63] — — U — I B CMOS —
Earthworm [65] — — — — I T — —
Cilia [67] — — — — I T — —
Paddling [105] — — — — I T — —
Anchor [18] — — — — I B — —
Anchor [17] — — — — I T — —
Earthworm [70] — — — — I T a —
Legged [10,71,72] — — B I I T/B CMOS —
Propeller [21] — — B — I B — —
Elec. Stim. [80] — — U — I B — —
Magnetic [91] — RF U — E B CMOS —
Magnetic [93] — RF U — E B CMOS —
Clip [96] — — B — E B — Clip
Biopsy [97] — — — — — W — Biopsy
Propeller [103] — — B — I W — —
Inflation [88] — — — — — B — Inflation
Autofocus [14] — — B — — B CMOS —
These fully robotic devices may be autonomous,
teleoperated, or some mixture of the two. Fully
autonomous systems require advanced intelligence to
locate, recognize, and treat the lesions they encounter
without the aid of real-time human decision mak-
ing. Internal locomotion appears most promising for
such systems, so that they can be used in many
different non-hospital settings, including being self-
administered by patients in their own homes. Signifi-
cant advancements will be required in power sources
and capsule intelligence to enable fully autonomous
capsules.
Another very different future fully robotic capsu-
lar device that can be envisioned is a teleoperated
system. A teleoperated capsule may work under the
control of a human operator who inputs commands
using a console similar to that of the da Vinci sys-
tem, Intuitive Surgical, Inc. Creating a teleoperated
capsule robot will require advancements in nearly all
modules discussed in this article. For example, image
capture, compression, and transmission techniques
will all have to improve to the point where real-time
video can be obtained from wireless capsules. The
capsule itself will also need to be instrumented with
miniature manipulators, and of course, a high energy
density power source. The future feasibility of includ-
ing all of these systems on one capsule is currently
unclear, but it is also conceptually possible to achieve
such goals via cooperative teams of capsules that work
together and/or assemble themselves into a larger
structure. Such future systems may also move beyond
the GI tract and into the abdomen in a NOTES-like
manner to perform scarless surgical interventions.
Regardless of the form future systems take, it is
clear that modern commercial WCEs have already
proven their diagnostic worth, and that swallowable
devices represent an important emerging area of med-
ical technology. The next fundamental leap forward
in capsule technology will be the inclusion of inter-
ventional capabilities onboard the capsule, and initial
prototype interventional devices have recently begun
to appear in research laboratories. Given the promise
of capsule robots in reducing the invasiveness, indig-
nity, financial costs, and anaesthesia-related risks in GI
procedures, the outlook for innovation in swallowable
devices is bright.
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